Back to: FDA Improving Anaphylaxis Outcomes: Approaches for Enhancing Access to Epinephrine
This session will examine promising approaches to increase access to and use of epinephrine, along with the authorities governing those measures. Reflecting on prior discussions, panelists will consider how various interventions may improve epinephrine access. Potential interventions include, but are not limited to, increased availability of methods for administration and educational resources informed by the latest clinical guidelines. Panelists will also discuss the feasibility of potential policy actions and the potential impact on anaphylaxis outcomes.
Moderator:
Julie Wang
Icahn School of Medicine at Mount Sinai
Panelists:
Timothy Dribin
Cincinnati Children’s Hospital Medical Center
Matthew Greenhawt
Asthma and Allergy Foundation of America
Nissa Shaffi
Allergy & Asthma Network
Marcus Shaker
Dartmouth College
Closing Remarks and Adjournment
Karen Murry
U.S. Food and Drug Administration